MED - medifastinc.com Operating profit before amortization

Brandmark of Medifast (MED)

Medifast, Inc. (MED) combines in-house production with external IT outsourcing. Leadership in the wellness niche is driven by unique OPTAVIA coaching. The baseline EBITDA demonstrates a balance between supply and demand, while 0.00 determines the latest valuation metric. However, the expansion of new weight-loss drugs poses serious threats to revenue and the stability of the mentor network.

Operating profit EBITDA: Medifast Inc. (MED) for 11/23/2025 - 11/12/2026

Summary analytical data breakdowns for Medifast (MED)

- market value and analyst target forecast:
Market Price Medifast, Inc|MED - Analyst Consensus Forecast
- market capitalization statistics:
Market Capitalization Medifast|MED - Enterprise Value
- balance sheet net asset value indicators:
Net Assets per Share Medifast|MED - Book Capitalization|Market Capitalization to Net Assets medifastinc.com|MED - Company Total Assets
- business debt structure and liquidity details:
Total Debt to Capital Medifast, Inc.|MED - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient Medifast Inc.|MED - Company Total Debt|Debt to Book Capital Medifast|MED - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Medifast|Interim Coverage Ratio medifastinc.com
- company profitability and valuation multiples indicators:
MED - Company Net Income|Net Profit Forecast Medifast, Inc.|MED - P/E Multiple|Projected Price to Earnings medifastinc.com|MED - Price/Earnings to Growth Multiple|Total Company Value to Operating Income Before Depreciation Ratio Medifast|MED - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Medifast|MED - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months medifastinc.com|MED - Earnings growth in current year|Projected earnings per share growth rate for next year Medifast, Inc.
Fundamental company valuation:Medifast, Inc MED
Original product of OPTAVIA

This indicator tracks daily cash flow from core operations before depreciation and interest, allowing investors to monitor real-time operational efficiency. Analyzing absolute EBITDA helps assess the success of Medifast, Inc. (MED) in optimizing costs and adapting weight loss programs to compete with GLP-1 drugs, revealing the true resilience of the business model prior to the release of quarterly reports.

Competitor analysis for Medifast, Inc.

Amer Sports Group (AS) - Profit before interest, taxes and amortization|Planet Fitness, Inc. - Operating profit EBITDA|LTH (Life Time Fitness) - Operating profit before amortization|PTON: Operating profit EBITDA|OSW - Operating income before deduction of amortization|HLF (Herbalife Ltd) - Operating profit EBITDA|Xponential - Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA AIRS|Operating profit EBITDA huami.com (ZEPP)|Profit before payment of interest, taxes and amortization WeightWatchers WW|Operating income before deduction of amortization FitLife Brands Inc. (FTLF)|ESCA: Operating profit before deduction of amortization|Fitness Champs Group - Company profit before taxes, interest and amortization|BODI (The Beachbody Company) - Operating profit before deduction of amortization|Mannatech - Income before deduction of interest, taxes and amortization|ALUR (Allurion) - Operating profit EBITDA|Perfect Moment Ltd. (PMNT) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Fitell Corporation (FTEL)|formelife.com - Operating profit before amortization|Operating profit EBITDA SMFL (Smart for Life, Inc.)